SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-20-010161
Filing Date
2020-04-29
Accepted
2020-04-29 17:04:44
Documents
5
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10011013x3_defa14a.htm DEFA14A 25612
2 nc10011013x3_nc1.jpg GRAPHIC 1970250
3 nc10011013x3_nc2.jpg GRAPHIC 2745518
4 nc10011013x3_nc3.jpg GRAPHIC 900036
5 nc10011013x3_nc4.jpg GRAPHIC 441774
  Complete submission text file 0001140361-20-010161.txt   6298685
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36728 | Film No.: 20831392
SIC: 2836 Biological Products, (No Diagnostic Substances)